Adagene Inc. (FRA:978)
Germany · Delayed Price · Currency is EUR 3.060
0.00 (0.00%)
Last updated: Jun 15, 2026, 8:06 AM CET
Adagene Market Cap
Adagene has a market cap or net worth of €203.73 million as of June 15, 2026. Its market cap has increased by 152.94% in one year.
Market Cap
203.73M
Enterprise Value
157.93M
Revenue
6.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.06
Market Cap Chart
Since February 9, 2021, Adagene's market cap has decreased from 1.05B to 203.73M, a decrease of -80.52%. That is a compound annual growth rate of -26.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 207.29M | 173.23% |
| Dec 31, 2025 | 75.87M | -10.84% |
| Dec 31, 2024 | 85.09M | 11.10% |
| Dec 29, 2023 | 76.59M | 42.27% |
| Dec 30, 2022 | 53.84M | -82.59% |
| Dec 31, 2021 | 309.16M | -70.44% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.27B |
| Darwin AG | 72.00M |
| 2invest AG | 47.16M |
| Biomark Diagnostics | 33.65M |
| Vidac Pharma Holding | 28.81M |
| co.don AG | 400.85K |
| Paion AG | 378.09K |
| bioXXmed AG | 222.93K |